Business
Novartis Pays $125M for a Way to Sneak Big Drugs Past the Brain’s Border Wall
The blood-brain barrier blocks most large-molecule drugs from reaching the brain. Novartis is buying Sironax’s delivery technology to get antibodies, proteins and gene therapies through it.